Liensinine attenuates inflammation and oxidative stress in spleen tissue in an LPS-induced mouse sepsis model.
- Author:
Hanyu WANG
1
;
Yuanhao YANG
2
;
Xiao ZHANG
1
;
Yan WANG
2
;
Hui FAN
1
;
Jinfeng SHI
1
;
Xuelian TAN
1
;
Baoshi XU
1
;
Jingchao QIANG
1
;
Enzhuang PAN
1
;
Mingyi CHU
1
;
Zibo DONG
3
;
Jingquan DONG
4
Author Information
- Publication Type:Journal Article
- MeSH: Mice; Animals; Lipopolysaccharides/pharmacology*; Spleen; Inflammation; Apoptosis; Sepsis; Oxidative Stress
- From: Journal of Zhejiang University. Science. B 2023;24(2):185-190
- CountryChina
- Language:English
- Abstract: Sepsis is a complex syndrome caused by multiple pathogens and involves multiple organ failure, particularly spleen dysfunction. In 2017, the worldwide incidence was 48.9 million sepsis cases and 11 million sepsis-related deaths were reported (Rudd et al., 2020). Inflammation, oxidative stress, and apoptosis are the most common pathologies seen in sepsis. Liensinine (LIE) is a bisbenzylisoquinoline-type alkaloid extracted from the seed embryo of Nelumbo nucifera. Lotus seed hearts have high content of LIE which mainly has antihypertensive and antiarrhythmic pharmacological effects. It can exert anti-carcinogenic activity by regulating cell, inflammation, and apoptosis signaling pathways (Manogaran et al., 2019). However, its protective effect from sepsis-induced spleen damage is unknown. In this research, we established a mouse sepsis model induced by lipopolysaccharide (LPS) and investigated the protective effects of LIE on sepsis spleen injury in terms of inflammatory response, oxidative stress, and apoptosis.